ThermoGenesis (KOOL +3.3%) moves up after saying it has signed two new channel partner...
ThermoGenesis (KOOL +3.3%) moves up after saying it has signed two new channel partner agreements in an effort to enhance its distribution, technical service and clinical support initiatives of its cord blood products. Under the new agreement with HVD Biotech Vertriebs will have exclusive distribution rights for KOOL's AXP AutoXpress System and BioArchive System in 10 European countries.
From other sites
at Benzinga.com (Jan 2, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs